AFM
EVAR

Anson Funds Management’s Lombard Medical, Inc. EVAR Stock Holding History

Anson Funds Management’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-249,603
Closed -$337K – 100
2015
Q4 		$337K Buy
+249,603
New +$590K 0.11% 57

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return

Anson Funds Management's EVAR Position: Q1 2016 in Review

Anson Funds Management sold out of Lombard Medical, Inc. (EVAR) in Q1 2016, closing a stake of 249,603 shares — an estimated $337K sold.

Anson Funds Management first reported a position in EVAR in Q4 2015 and held it in 1 quarter. The position peaked at $337K in Q4 2015. 18 funds tracked by Wall St. Rank hold EVAR as of Q1 2016.

  • Anson Funds Management reported no remaining Lombard Medical, Inc. position as of Q1 2016 after selling out during the quarter.
  • Anson Funds Management sold 249,603 Lombard Medical, Inc. shares in Q1 2016, an estimated $337K.
  • Anson Funds Management first reported a position in Lombard Medical, Inc. in Q4 2015 and held it in 1 quarter.
  • Anson Funds Management's Lombard Medical, Inc. position peaked at $337K in Q4 2015.
  • 18 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q1 2016.

Based on Anson Funds Management's 13F filing for Q1 2016, filed 13 May 2016.